Cargando…
Micropulse Transscleral Cyclophotocoagulation as Primary Surgical Treatment for Primary Open Angle Glaucoma in Taiwan during the COVID-19 Pandemic
Glaucoma is the leading cause of irreversible blindness worldwide, with primary open angle glaucoma (POAG) accounting for the greatest number of total glaucoma cases. This study aimed to evaluate the efficacy and safety of micropulse transscleral cyclophotocoagulation (MP-TSCPC) as a primary procedu...
Autores principales: | Chang, Hsiao-Ling, Chao, Shih-Chun, Lee, Ming-Tsung, Lin, Hung-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625108/ https://www.ncbi.nlm.nih.gov/pubmed/34828609 http://dx.doi.org/10.3390/healthcare9111563 |
Ejemplares similares
-
Micropulse Transscleral Cyclophotocoagulation
por: Abdelmassih, Youssef, et al.
Publicado: (2021) -
Micropulse Transscleral Cyclophotocoagulation Results in Secondary Glaucoma
por: Szilagyi, Zsuzsa, et al.
Publicado: (2023) -
Micropulse Transscleral Cyclophotocoagulation for Glaucoma after Penetrating Keratoplasty
por: Zemba, Mihail, et al.
Publicado: (2022) -
Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation
por: de Vries, Victor. A., et al.
Publicado: (2022) -
Micropulse vs. continuous wave transscleral cyclophotocoagulation in neovascular glaucoma
por: Zemba, Mihail, et al.
Publicado: (2022)